The safety and effectiveness of salvianolate in preventing perioperative venous thromboembolism in China: A PRISMA-compliant meta-analysis based on RCTs.

ABSTRACT:

Background

Salvianolate, a common drug for stabilizing heart disease and Angina Pectoris, is considered to be off-label for preventing venous thromboembolism (VTE) or anticoagulation at present. However, many clinical studies have showed that salvianolate can effectively inhibit the deep-vein thrombosis (DVT) incidence, and prevent VTE of perioperative patients in the real world in China.

Objective

This analysis aimed to evaluate the effectiveness and safety of salvianolate in preventing VTE in perioperative patients.

Methods

Databases of PubMed, Cochrane Library, Embase, CNKI, Wanfang and VIP were searched until July 2019. Literature retrieval, data extraction and quality assessment were independently completed by two researchers and checked with each other. Review M

SUBMITTER: Chai YN 

PROVIDER: S-EPMC8104266 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature